64.8K
Publications
7.9M
Citations
176.6K
Authors
13.8K
Institutions
Table of Contents
In this section:
In this section:
In this section:
In this section:
In this section:
[2] Computational biology - Wikipedia — Computational biology refers to the use of techniques in computer science, data analysis, mathematical modeling and computational simulations to understand biological systems and relationships. An intersection of computer science, biology, and data science, the field also has foundations in applied mathematics, molecular biology, cell biology, chemistry, and genetics. Computational biology: The development and application of data-analytical and theoretical methods, mathematical modeling and computational simulation techniques to the study of biological, behavioral, and social systems. Bioinformatics: Research, development, or application of computational tools and approaches for expanding the use of biological, medical, behavioral or health data, including those to acquire, store, organize, archive, analyze, or visualize such data. ^ a b c d e "NIH working definition of bioinformatics and computational biology" (PDF).
[4] What is Computational Biology? - Dovetail Biopartners — It involves the development and application of computational algorithms, statistical models, and data analysis techniques to analyze and interpret biological data. By using computational tools and techniques, researchers can analyze biological data, identify patterns, and make predictions about biological systems. Finally, data mining and machine learning techniques empower us to extract valuable insights from massive biological datasets, paving the way for new discoveries and advancements in the field of computational biology. Computational biology plays a crucial role in this approach by analyzing genomic data and providing insights into disease susceptibility, treatment response, and potential adverse reactions. From decoding the genome to predicting protein structures, from modeling complex biological systems to personalized medicine, computational biology has made significant contributions across various fields of research and beyond.
[5] What is Computational Biology? - Ray and Stephanie Lane Computational ... — - Ray and Stephanie Lane Computational Biology Department - School of Computer Science - Carnegie Mellon University Computational biology is the science that answers the question “How can we learn and use models of biological systems constructed from experimental measurements?” These models may describe what biological tasks are carried out by particular nucleic acid or peptide sequences, which gene (or genes) when expressed produce a particular phenotype or behavior, what sequence of changes in gene or protein expression or localization lead to a particular disease, and how changes in cell organization influence cell behavior.
[6] Recent breakthroughs in computational structural biology harnessing the ... — Theoretical modeling and machine learning methods enable accurate protein structure prediction. Recent years have witnessed substantial developments in computational biology at several scales (Figure 1), enabling the structural and functional characterization of an unprecedented number of proteins and protein complexes, as well as modulating and designing the interactions and functionalities of these molecules. New theoretical models and algorithms, primarily rooted in Machine Learning (ML) or deep learning, are becoming the new de facto standard in many areas of computational structural biology, enabling the prediction of protein structures in the hundreds of millions . Others are directly integrated into experimental workflows for structure determination, with modeling of large protein complexes and Molecular Dynamics (MD) simulations being core components of integrative structural biology.
[7] Machine Learning in Computational Biology | SpringerLink — Machine learning currently offers some of the most cost-effective tools for building predictive models from biological data, e.g., for annotating new genomic sequences, for predicting macromolecular function, for identifying functionally important sites in proteins, for identifying genetic markers of diseases, and for discovering the networks of genetic interactions that... Berman H.M., Westbrook J., Feng Z., Gilliland G., Bhat T.N., Weissig H., Shindyalov I.N., and Bourne P.E. The protein data bank. Bruggeman F.J. and Westerhoff H.V. The nature of systems biology. Caragea C., Sinapov J., Dobbs D., and Honavar V. 320–326. 1–15. 15–30. Learn., 52:147–167, 2007. Terribilini M., Lee J.-H., Yan C., Jernigan R.L., Honavar V, and Dobbs D. Yan C., Terribilini M., Wu F., Jernigan R.L., Dobbs D., and Honavar V.
[8] AI: A transformative opportunity in cell biology — Harnessing the power of data and AI. The advent of AI-driven protein structure prediction models, represent landmark, interdisciplinary achievements in structural biology, computational biology, and computer science (Jumper et al., 2021).These breakthroughs were made possible by harnessing the wealth of data in the Protein Data Bank (PDB), a comprehensive repository of carefully curated and
[9] Computational Biology: Transforming Biomedical Research and Healthcare — The integration of Artificial Intelligence (AI) and Machine Learning (ML) with computational biology is opening new avenues for research and healthcare. AI and ML algorithms can analyze complex and high-dimensional biological data, uncovering patterns and relationships that are difficult to detect with traditional methods.
[10] Applying interpretable machine learning in computational biology ... — Machine learning has greatly shaped the landscape of computational biology, with the integration of high-throughput data acquisition and burgeoning computational power leading to the creation of
[11] The Applications of Machine Learning in Biology — Dr. Ragothanam Yennamalli, a computational biologist and Kolabtree freelancer, examines the applications of AI and machine learning in biology. While there are many applications for machine learning methods, their applications to biological data since the last 30 years or so have been in gene prediction, functional annotation, systems biology, microarray data analysis, pathway analysis, etc. The processes of machine learning are quite similar to predictive modelling and data mining. Neural network-based machine learning algorithms needs refined or significant data from raw data sets to perform analysis. Today, scientists use deep learning algorithms to perform classification of cellular images, genome analysis, drug discovery and also find out how image data and genome data are link with electronic medical records.
[12] Machine Learning in Computational Biology | SpringerLink — Although many machine learning algorithms have had significant success in computational biology, several challenges remain. These include the development of: efficient algorithms for learning predictive models from distributed data; cumulative learning algorithms that can efficiently update a learned model to accommodate changes in the underlying data used to train the model; effective methods
[14] Machine Learning in Biological Sciences - Springer — This book gives an overview of applications of Machine Learning (ML) in diverse fields of biological sciences, including healthcare, animal sciences, agriculture, and plant sciences. Machine learning has major applications in process modelling, computer vision, signal processing, speech recognition, and language understanding and processing and
[37] Computational Biology: Moving into the Future One Click at a Time — Markel, like many of his ISCB colleagues, considers the sequencing of the human genome as a major research landmark for computational biology and a powerful driver of the technologies and software developed over the last two decades for sequencing and genomics. Thornton reflected on some of the most interesting observations and results to come out of the increasingly diverse corpus of computational biology research—in particular, the use of genomics to identify how microbes evolve during an epidemic, genomic approaches to understanding human evolution, GWAS studies to discern how genetic variants impact disease, the discovery of the breadth of the microbiome and how bacterial populations interact and influence each other, the use of electronic health records to extract clinical data, and the observation that regulatory processes evolve relatively quickly in comparison to protein sequences and structures.
[38] A brief history of bioinformatics - PubMed — A brief history of bioinformatics - PubMed Your saved search Name of saved search: A brief history of bioinformatics A brief history of bioinformatics The foundations of bioinformatics were laid in the early 1960s with the application of computational methods to protein sequence analysis (notably, de novo sequence assembly, biological sequence databases and substitution models). Later on, DNA analysis also emerged due to parallel advances in (i) molecular biology methods, which allowed easier manipulation of DNA, as well as its sequencing, and (ii) computer science, which saw the rise of increasingly miniaturized and more powerful computers, as well as novel software better suited to handle bioinformatics tasks. Chakraborty C, et al. Bioinformatics. doi: 10.1093/bioinformatics/btg309. Bioinformatics. Mi X, et al.
[39] Computing in the Life Sciences: From Early Algorithms to Modern AI — Computing in the life sciences has undergone a transformative evolution, from early computational models in the 1950s to the applications of artificial intelligence (AI) and machine learning (ML) seen today. This paper highlights key milestones and technological advancements through the historical development of computing in the life sciences. The discussion includes the inception of
[41] The Human Genome Project: big science transforms biology and medicine — The Human Genome Project: big science transforms biology and medicine - PMC The Human Genome Project: big science transforms biology and medicine The Human Genome Project has transformed biology through its integrated big science approach to deciphering a reference human genome sequence along with the complete sequences of key model organisms. First, the human genome sequence initiated the comprehensive discovery and cataloguing of a ‘parts list’ of most human genes , and by inference most human proteins, along with other important elements such as non-coding regulatory RNAs. Understanding a complex biological system requires knowing the parts, how they are connected, their dynamics and how all of these relate to function . The HGP benefited biology and medicine by creating a sequence of the human genome; sequencing model organisms; developing high-throughput sequencing technologies; and examining the ethical and social issues implicit in such technologies.
[43] Human genome sequencing powers personalized, precision medicine — With NIH support, a consortium of scientists from institutions around the world, including Johns Hopkins, were able to map the human genome, helping advance our understanding of genetic risk factors for diseases like cancer In 2022, the Telomere-to-Telomere Consortium, a group of NIH-funded scientists from research institutions around the world, including Johns Hopkins, achieved a monumental scientific breakthrough: They produced the first fully completed sequence of a human genome. A Johns Hopkins geneticist who's part of the T2T Consortium, Rajiv McCoy, explains the importance of this project: "A more complete view of variation within our genomes is foundational to advancing research on cancer, aging, and infertility, as well as countless other aspects of human health.
[45] Exploring the intersection of mechanobiology and artificial intelligence — In this regard, artificial intelligence approaches may enable several transformative advances in research, such as advanced data analysis (e.g. live-cell imaging, cellular pattern recognition), predictive modeling (e.g., mechanical properties of tissue and cells), automation of experimental procedures (e.g., atomic force microscopy, tweezers), integration of multi-scale data (from cells to tissues), or new insights into mechanotransduction pathways (e.g., gene networks, protein interactions, and cellular pathways). c Measurements of forces from different techniques, either at the multi-cell level (such as fluorescence and light microscopy or AFM curves) or at the bulk and single-cell level (such as DNA/RNA sequencing or genomic enrichment) are used as inputs for machine learning (ML) or artificial intelligence (AI)-based algorithms, which are then trained to provide outputs and predictions such as the cell and ECM mechanical properties, cell states and heterogeneity, or protein structure and gene expression.
[48] Integrating artificial intelligence in drug discovery and early drug ... — There are several limitations, specific to drug discovery and development in cancer, that can be summarized in the following concepts: (1) High Costs and Long Timelines: 10–15 years for a drug candidate to receive regulatory approval ; (2) Low Success Rates: approximately 90% of candidates that enter early clinical trials do not reach the market ; and (3) Complex Disease Biology: cancer involves complex, interconnected biological pathways that are difficult to target effectively with classical methods. As the main reasons for failures in drug development are insufficient efficacy and safety levels, methods based on AI could help mitigate challenges in the analysis of multiomics data by improving target identification and predicting druggability, which enhances the overall drug discovery process. An example of the integration of biological data for drug identification is PaccMann, an AI-driven framework designed to predict cancer cell sensitivity to compounds by integrating molecular structures, gene expression profiles, and protein interaction data.
[49] PDF — AI empowers data-driven biology Current breakthroughs in AI are rapidly expanding the capacities of computational biology. Emerging AI technologies (e.g., large language models, diffusion models, and multimodal modeling) can inspire and advance the development of powerful algo-rithms for computational biology, especially in the following aspects.
[57] large-scale assessment of sequence database search tools for homology ... — These four programs can utilize a protein sequence database after a straightforward reformatting process to convert the database text into binary formats. ... To delve further into the impact of different sequence search tools on function prediction, we use the TMTC4 protein from the fruit fly (UniProt accession: Q9VF81) as a case study
[58] Understanding Protein Databases: Structure and Function — The selection of the appropriate database can greatly enhance the quality of scientific research and data analysis. Key Components of Protein Databases. Protein databases are integral to the field of bioinformatics, acting as repositories for data that facilitate research in molecular biology, genetics, and biochemistry.
[82] Recent advances in computational algorithms and software for large ... — Current Opinion in Chemical Biology. Volume 72, February 2023, 102238. Recent advances in computational algorithms and software for large-scale glycoproteomics. ... graph-based approach was also implemented in pGlyco3 with several computational advances that resulted in greatly improved speed . The paired-scan methods combine the dramatic
[83] 9 Computational Biology Trends in 2023 | StartUs Insights — Explore our in-depth industry research on 494 computational biology startups & scaleups and get data-driven insights into technology-based solutions in our Computational Biology Innovation Map! These trends are enabling novel drug development, nutrition analytics, and cancer therapies. Innovation Map outlines the Top 9 Computational Biology Trends & 18 Promising Startups For this in-depth research on the Top Computational Biology Trends & Startups, we analyzed a sample of 494 global startups & scaleups. Machine learning-based solutions automate processes across biotech, pharma, and other life sciences sectors.
[85] Recent breakthroughs in computational structural biology harnessing the ... — Theoretical modeling and machine learning methods enable accurate protein structure prediction. Recent years have witnessed substantial developments in computational biology at several scales (Figure 1), enabling the structural and functional characterization of an unprecedented number of proteins and protein complexes, as well as modulating and designing the interactions and functionalities of these molecules. New theoretical models and algorithms, primarily rooted in Machine Learning (ML) or deep learning, are becoming the new de facto standard in many areas of computational structural biology, enabling the prediction of protein structures in the hundreds of millions . Others are directly integrated into experimental workflows for structure determination, with modeling of large protein complexes and Molecular Dynamics (MD) simulations being core components of integrative structural biology.
[86] Computational biology and bioinformatics - Latest research and news ... — Advertisement View all journals Search Log in nature subjects computational biology and bioinformatics Computational biology and bioinformatics articles from across Nature Portfolio Atom RSS Feed DefinitionComputational biology and bioinformatics is an interdisciplinary field that develops and applies computational methods to analyse large collections of biological data, such as genetic sequences, cell populations or protein samples, to make new predictions or discover new biology. The computational methods used include analytical methods, mathematical modelling and simulation. Here, the authors develop a machine learning approach to infer cancer cell drug sensitivity from transcriptomics data and to explore drug mechanisms of action, and predict effective drugs for pancreatic cancer and glioblastoma. Here, authors introduce “Native Fold Delay”, integrating protein topology with translation kinetics to quantify the resulting delays in co-translational folding which may result in protein aggregation.
[87] Advances in Computational Systems Biology: A Comprehensive Overview — Computational systems biology represents a convergence of multiple disciplines, offering powerful tools and methodologies to study complex biological systems. Advances in computational power, high-throughput technologies, and sophisticated modeling techniques have driven the growth of this field.
[95] Next-Generation Machine Learning for Biological Networks - Cell Press — Next-Generation Machine Learning for Biological Networks: Cell By enabling one to generate models that learn from large datasets and make predictions on likely outcomes, machine learning can be used to study complex cellular systems such as biological networks. These reverse-engineering approaches have shown a remarkable ability to learn patterns from input data to generate biologically relevant gene regulatory networks, with interesting applications in the identification of drivers of drug response or disease phenotypes (e.g., Akavia et al., 2010; di Bernardo et al., 2005; Costello et al., 2014; Walsh et al., 2017). This Review is intended for biological researchers who are curious about recent developments and applications in machine learning and its potential for advancing network biology given the vast amounts of data being generated today.
[118] The Growing Impact of Lab Automation in the Drug Discovery Market — By improving speed, accuracy, and efficiency, lab automation is driving the future of drug discovery, enabling pharmaceutical companies to bring new therapies to market faster and at a lower cost.
[135] Integrating artificial intelligence in drug discovery and early drug ... — There are several limitations, specific to drug discovery and development in cancer, that can be summarized in the following concepts: (1) High Costs and Long Timelines: 10–15 years for a drug candidate to receive regulatory approval ; (2) Low Success Rates: approximately 90% of candidates that enter early clinical trials do not reach the market ; and (3) Complex Disease Biology: cancer involves complex, interconnected biological pathways that are difficult to target effectively with classical methods. As the main reasons for failures in drug development are insufficient efficacy and safety levels, methods based on AI could help mitigate challenges in the analysis of multiomics data by improving target identification and predicting druggability, which enhances the overall drug discovery process. An example of the integration of biological data for drug identification is PaccMann, an AI-driven framework designed to predict cancer cell sensitivity to compounds by integrating molecular structures, gene expression profiles, and protein interaction data.
[141] The rise of the genome and personalised medicine - PMC — As set out in the Annual report of the Chief Medical Officer 2016: Generation Genome_1 and the recent NHS England board paper _Creating a genomic medicine service to lay the foundations to deliver personalised interventions and treatments,2 the increasing ‘mainstreaming’ of genetic testing into routine practice and plans to embed whole genome sequencing in the NHS mean that the profile and importance of genomics is on the rise for many clinicians. Every human genome contains around 3–5 million genetic variants compared with the reference sequence. Genomic medicine has the capacity to revolutionise the healthcare of an individual with a rare disease or cancer by offering prompt and accurate diagnosis, risk stratification based upon genotype and the capacity for personalised treatments.
[142] Testing personalized medicine: patient and physician expectations of ... — Developments in genomics, including next-generation sequencing technologies, are expected to enable a more personalized approach to clinical care, with improved risk stratification and treatment selection. In oncology, personalized medicine is particularly
[143] Genomic sequencing: the case for equity of care in the era of ... — Rapid genomic sequencing for genetic disease diagnosis and therapy in intensive care units: a review. Exome and genome sequencing for pediatric patients with congenital anomalies or intellectual disability: an evidence-based clinical guideline of the American College of Medical Genetics and Genomics (ACMG). Genetic Health Professionals’ Experiences Obtaining Informed Consent in Diagnostic Genomic Sequencing. J. Managing the ethical challenges of next-generation sequencing in genomic medicine. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. Ghaloul-Gonzalez, L., Parker, L.S., Davis, J.M. et al.
[160] About the Program - Biophysics, Structural & Computational Biology ... — The program of instruction is designed to readily accommodate students with backgrounds in physical sciences but little previous exposure to biology. Program Size The program currently encompasses approximately 25 students of diverse nationalities and backgrounds. 5-6 new students matriculate each year. 29 faculty members contribute to the
[165] Computational biology: Computational Biology: Bridging the Gap Between ... — Challenges and Limitations in Computational Biology: 1. Data Complexity and Volume: - The sheer volume of biological data generated by high-throughput techniques can be overwhelming. For example, a single run of next-generation sequencing can produce terabytes of data, posing significant challenges in data storage, processing, and analysis.
[169] Perspectives on computational modeling of biological systems and the ... — Computational models that integrate such diverse data sets employing mathematical, machine learning (ML), and artificial intelligence (AI) approaches are crucial to study complexity of biological processes (Fig. 1) and for more targeted and effective therapeutic interventions, shaping the future of personalized medicine and biotechnology (Alber et al., 2019). Computational models that include single-cell data enhance our understanding of tumour evolution, the dynamics of cancer progression, and the biological processes in cancer (Bakr et al., 2023), thereby informing more effective treatment strategies. In 2016, a community was founded for the Computational Modeling of Biological Systems (SysMod) as a Community of Special Interest (COSI) of the International Society for Computational Biology (ISCB) (Dräger et al., 2021, Niarakis et al., 2022, Puniya and Dräger, 2023). SysMod: the ISCB community for data-driven computational modelling and multi-scale analysis of biological systems.
[170] Multi-OMICS approaches in cancer biology: New era in cancer therapy — In multi-omics in cancer refers to the application of network-based approaches to integrate and analyze diverse omics data types in the context of cancer research. This paradigm recognizes that different molecular layers (genomics, transcriptomics, proteomics, metabolomics, etc.) are interconnected in complex ways within biological systems.
[171] Synthetic augmentation of cancer cell line multi-omic datasets using ... — Integrating diverse types of biological data is essential for a holistic understanding of cancer biology, yet it remains challenging due to data heterogeneity, complexity, and sparsity. Addressing this, our study introduces an unsupervised deep learning model, MOSA (Multi-Omic Synthetic Augmentation), specifically designed to integrate and
[175] Editorial: Computational Approaches to Study the Impact of Mutations on ... — The growing data on protein three-dimensional structure, along with variations observed in sequence data, will enable the development of new computational methods and tools to predict the impact of mutations on protein function, stability and interaction thereby aiding in the understanding of the basic mechanisms that govern disease conditions.
[177] Applications and challenges of high performance computing in ... - Springer — With the rapid development of high-throughput sequencing technologies, the scale of sequencing data continuously increases at unprecedented speed. In the field of genomics, high performance computing (HPC) is urgently needed to process these large-scale sequencing data, which uses supercomputers and parallel processing technologies to solve complex computing problems and performs intensive
[178] Next-generation sequencing: big data meets high performance computing — The analysis of the massive datasets produced by these instruments, however, poses difficult computational challenges. For example, it is projected that variant calling from NGS data alone requires around two trillion CPU hours by 2025 .As a consequence, optimized algorithms for commonly used tasks in NGS data processing are required that are scalable toward large input datasets.
[179] High-throughput DNA sequencing errors are reduced by orders of ... — A major limitation of high-throughput DNA sequencing is the high rate of erroneous base calls produced. For instance, Illumina sequencing machines produce errors at a rate of ~0.1-1 × 10(-2) per base sequenced. ... Computational Biology / methods* DNA, Circular / genetics* Gene Library
[211] Revolutionizing Personalized Medicine: Synergy with Multi-Omics Data ... — The history of personalized medicine is punctuated by significant milestones in genetics, technology, and clinical applications, shifting healthcare from a one-size-fits-all approach to a more individualized understanding of the molecular basis of health and disease and effective treatment strategies . Advances in genomics and biotechnology in the 21st century are enabling more personalized approaches to medicine, predicting disease risks, and tailoring treatments to individual genetic profiles. Personalized medicine leverages these images in conjunction with genetic data to gain deeper insights into disease mechanisms in individual patients, enhancing precision in diagnosis and treatment strategies . Through the integration of genetic, molecular, and clinical data, personalized medicine enables more accurate diagnosis, precise treatment targeting, and effective disease management.
[213] From byte to bench to bedside: molecular dynamics simulations and drug ... — Given these advancements, MD simulations are poised to become even more powerful tools for investigating the dynamic interactions between potential small-molecule drugs and their target proteins, with significant implications for pharmacological research. Structure-based computeraided drug design (CADD) further augments rational design by using computational methods to drastically reduce the physical experiments required for hit identification, making early-stage drug discovery more cost-effective and efficient. Molecular dynamics (MD) simulations have emerged as valuable tools for investigating the conformational diversity of ligand binding pockets. In this comment, we provide a concise overview of the intersection between MD simulations and CADD over the past two decades, emphasizing the advancements that have enhanced our understanding of protein flexibility and its profound impact on drug discovery.
[214] Role of Molecular Dynamics Simulations in Drug Discovery — Experimental methods alone cannot thoroughly investigate the mechanisms and interactions critical for drug development. Molecular dynamics simulations are extensively used in modern drug discovery and delivery, providing valuable information into the dynamical structures of macromolecules and protein-ligand interactions (2).MD helps assess the binding energetics and kinetics of ligand-receptor
[218] How Artificial Intelligence Is Changing Biomedical Research — The researchers, by training computers to sift through data from millions of human cells, created an AI program that can predict how genes, proteins, and other molecules in any given cell are likely to interact, based on how they’ve been observed to interact in other cells in the past. While other research groups have created AI tools to model activity within specific types of cells before, the new Columbia tool is the first to identify overarching patterns of molecular activity across all major cell types. “These kids inherit genes that are mutated, but until now nobody knew what they did,” says Rabadán, who also co-leads the cancer genomics and epigenomics research program at Columbia’s Herbert Irving Comprehensive Cancer Center.
[220] Machine Learning and Artificial Intelligence in Bioinformatics - Springer — Machine Learning and Artificial Intelligence in Bioinformatics | SpringerLink Machine Learning and Artificial Intelligence in Bioinformatics The integration of Machine Learning (ML) and Artificial Intelligence (AI) in bioinformatics has revolutionized the field by enabling the efficient analysis and interpretation of biological data. This chapter explores the significant impact of ML and AI in various bioinformatics applications, including drug discovery, personalized medicine, genomic analysis, and disease research, and discusses the utilization of ML algorithms such as neural networks, convolutional neural networks, random forests, and support vector machines to address challenges in genetic disease studies, cancer genetics, and personalized medicine. Machine learning in bioinformatics. Decision tree and ensemble learning algorithms with their applications in bioinformatics. https://doi.org/10.3390/j5020021. Machine learning in bioinformatics. Machine Learning and Artificial Intelligence in Bioinformatics.
[221] Future Trends in Bioinformatics AI Integration - Multimodal Data Fusion ... — The convergence of Artificial Intelligence (AI) and bioinformatics is reshaping the future of biological research and data analytics. ... AI introduces innovative methods, such as machine learning, deep learning, and natural language processing, which significantly enhance data analysis, optimize workflows, and unlock new avenues for discovery.
[223] Integrating artificial intelligence in drug discovery and early drug ... — There are several limitations, specific to drug discovery and development in cancer, that can be summarized in the following concepts: (1) High Costs and Long Timelines: 10–15 years for a drug candidate to receive regulatory approval ; (2) Low Success Rates: approximately 90% of candidates that enter early clinical trials do not reach the market ; and (3) Complex Disease Biology: cancer involves complex, interconnected biological pathways that are difficult to target effectively with classical methods. As the main reasons for failures in drug development are insufficient efficacy and safety levels, methods based on AI could help mitigate challenges in the analysis of multiomics data by improving target identification and predicting druggability, which enhances the overall drug discovery process. An example of the integration of biological data for drug identification is PaccMann, an AI-driven framework designed to predict cancer cell sensitivity to compounds by integrating molecular structures, gene expression profiles, and protein interaction data.
[224] The next revolution in computational simulations: Harnessing AI and ... — The next revolution in computational simulations: Harnessing AI and quantum computing in molecular dynamics - ScienceDirect The next revolution in computational simulations: Harnessing AI and quantum computing in molecular dynamics The integration of artificial intelligence, machine learning and quantum computing into molecular dynamics simulations is catalyzing a revolution in computational biology, improving the accuracy and efficiency of simulations. While the integration of artificial intelligence and quantum computing with MD simulations provides insightful and stimulating improvements to our understanding of molecular mechanisms, it could introduce new issues related to data quality, interpretability of models and computational complexity. © 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
[231] The Human Genome Project (HGP) & the role of bioinformatics (before ... — Bioinformatics tools were used to process and analyze the billions of DNA sequences generated by the project, to assemble those sequences into a complete genome sequence, and to annotate the
[232] Novel sequencing technologies and bioinformatic tools for deciphering ... — Read alignment is the single most time consuming computational analysis step. Unless special hardware, e. g., field-programmable gate arrays (FPGA), specifically designed for the read alignment task is used [], this step takes hours for whole genome data.Each of the millions of reads resulting from each genome needs to be compared to the roughly 3 billion base pairs of the human reference